Skip to main content
Current Neuropharmacology aims to provide current, timely and comprehensive reviews of all areas of neuropharmacology and related matters of neuroscience. The journal publishes reviews written by experts and leaders in the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Publisher: Bentham Science Publishers

More about this publication?
Volume 14, Number 3, 2016

Articles

Free Content Graphical Abstracts:
pp. i-iii(3)

Favourites:
ADD

Free Content Meet Our Editorial Board Member:
pp. 211-211(1)
Author: Alkadhi, Karim

Favourites:
ADD
Favourites:
ADD

Modulating the Amyloidogenesis of α-Synuclein
pp. 226-237(12)
Authors: Sivanesam, Kalkena; H. Andersen, Niels

Favourites:
ADD

Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
pp. 238-249(12)
Authors: Rivero-Ríos, Pilar; Madero-Pérez,, Jesús; Fernández, Belén; Hilfiker, Sabine

Favourites:
ADD
Favourites:
ADD

Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
pp. 260-271(12)
Authors: Filograna, Roberta; Beltramini, Mariano; Bubacco, Luigi; Bisaglia, Marco

Favourites:
ADD

Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
pp. 272-281(10)
Authors: Huang, Chi-Hsien; Huang, Chia-Chen; Sun, Cheuk-Kwan; Lin, Gong-Hong; Hou, Wen-Hsuan

Favourites:
ADD

Selenium in the Therapy of Neurological Diseases. Where is it Going?
pp. 282-299(18)
Authors: Dominiak, Agnieszka; Wilkaniec, Anna; WroczyŦ#132;ski, Piotr; Adamczyk, Agata

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content